F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea
Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration on Friday approved the weight loss drug Zepbound to treat obstructive sleep apnea. It is the first prescription medication approved to treat the common sleep disorder.
The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and ...
Approval for use beyond weight-loss could be a shot in the arm for the companies at a time when demand for the drugs is already surging. Obstructive sleep apnea affects roughly 1 billion ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback